Archives for September 8, 2009

← 2009

FDA places import alert on two Apotex facilities

By Nick Taylor

The FDA has issued an import alert against products manufactured at two Apotex facilities after the agency issued a warning letter, which raised several issues that the company is now working to resolve.

Bangladesh a “huge opportunity” for growth; CEO

By Nick Taylor

Bangladesh represents a “huge opportunity” to pharma, according to the CEO of Amreteck Pharma who believes that CMOs will be attracted by the low costs, which undercut China, and help the industry grow to $10bn (€6.9m) in 10 years.

Solvay cell-based vaccine facility validated

By Nick Taylor

Dutch authorities have completed validation of Solvay Biologicals cell-based production facility which the company will use to meet growing worldwide demand for influenza vaccines.

ChemBridge adds top libraries to CDD’s discovery database

By Gareth Macdonald

US discovery chemistry contractor ChemBridge has made some of its most popular small molecule libraries available on-line through a partnership with preclinical data specialist Collaborative Drug Discovery (CDD).

Lab Research lands new preclinical R&D contracts

By Gareth Macdonald

New multi-million dollar R&D contracts with top three pharma and biotech players go someway to “alleviating” the negative impact of downturn, according to Lab Research CEO Luc Mainville.

Transcrip offers experts to augment in-house drug development

By Gareth Macdonald

Transcrip Partners’ “augmentation” solution for contract R&D “differs from the normal consultancy alternative by fielding ‘doers’ who can think strategically and ‘thinkers’ who are happy to get their hands dirty” according to senior partner Paul Branthwaite.